FLEXION THERAPEUTICS INC's ticker is FLXN and the CUSIP is 33938J106. A total of 135 filers reported holding FLEXION THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $608,000 | +13.6% | 23,511 | -1.6% | 0.43% | +5.6% |
Q1 2018 | $535,000 | -10.5% | 23,892 | 0.0% | 0.41% | -11.8% |
Q4 2017 | $598,000 | +31.1% | 23,892 | +26.7% | 0.47% | +15.6% |
Q3 2017 | $456,000 | +70.8% | 18,853 | +89.9% | 0.40% | +93.8% |
Q1 2017 | $267,000 | – | 9,926 | – | 0.21% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Novo Holdings A/S | 1,500,000 | $36,270,000 | 4.72% |
Gagnon Advisors, LLC | 108,498 | $2,623,000 | 1.99% |
NEXTHERA CAPITAL LP | 271,136 | $6,556,000 | 1.69% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 883,321 | $21,359,000 | 1.39% |
GILDER GAGNON HOWE & CO LLC | 3,961,647 | $95,793,000 | 1.35% |
GAGNON SECURITIES LLC | 144,331 | $3,490,000 | 1.30% |
MILLER VALUE PARTNERS, LLC | 1,181,325 | $28,564,000 | 1.23% |
SCHOLTZ & COMPANY, LLC | 55,250 | $1,336,000 | 1.05% |
ARDSLEY ADVISORY PARTNERS LP | 175,000 | $4,232,000 | 0.56% |
Ratan Capital Management LP | 32,077 | $776,000 | 0.47% |